source
- Lung cancer abstracts set to shape discussions at ASCO 2026OncLive has compiled a preview of lung‑cancer presentations that leading oncologists expect to influence clinical talks at the 2026 ASCO Annual Meeting in Chicago. The preview highlights insights f…
- FDA agrees to revisit rare blood cancer drug Ebvallo after companies address concernsTwo companies developing a therapy for a rare blood cancer have reached an agreement with the FDA to address the agency’s concerns about their drug Ebvallo. The FDA had previously rejected Ebvallo…